CA Patent

CA2568834A1 — Medicaments for inhalation comprising steroids and an anticholinergic

Assigned to Boehringer Ingelheim International GmbH · Expires 2006-01-12 · 20y expired

What this patent protects

The present invention relates to novel pharmaceutical compositions based on steroids and salts of an anticholinergic especially a glycopyrrolate, processes for preparing them and their use in the treatment of respiratory complaints, particularly asthma or chronic obstructive pulm…

USPTO Abstract

The present invention relates to novel pharmaceutical compositions based on steroids and salts of an anticholinergic especially a glycopyrrolate, processes for preparing them and their use in the treatment of respiratory complaints, particularly asthma or chronic obstructive pulmonary disease (COPD).

Drugs covered by this patent

Patent Metadata

Patent number
CA2568834A1
Jurisdiction
CA
Classification
Expires
2006-01-12
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.